Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04194164 · ClinicalTrials.gov registry record · NA
Development of Fluid Intake App for Management of Fluid Intake During Hemodialysis , Full Scale Trial
A NA study of Weight Gain, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT04194164: Completed NA study of Weight Gain, sponsored by Wake Forest University Health Sciences.
NCT04194164 is a NA study of Weight Gain that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 33 participants, below the 221-participant average among 38 other Weight Gain trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04194164, a NA study of Weight Gain, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
Methods are needed to help decrease interdialytic weight gains in hemodialysis patients. One potential method for accomplishing this goal is to develop an app for smartphones that allow patients to track their fluid intake throughout the course of the day. NCT 03759847 was designed to test the safety and efficacy of this app. In this protocol, part of the same IRB number, patients with large interdialytic fluid gains (3.5% or greater) will use the app to to determine the association between the interdialytic weight gain and the fluid consumed as recorded by use of the app for each interdialytic period.
Primary Outcome
Comparison of interdialytic weight change before and during use of the app
Conditions Studied
Interventions
- OTHER Fluid intake app
Study Locations (1)
North Carolina
- Wake Forest School of Medicine - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-12-02 |
| Est. Completion | 2021-11-01 |
| Phase | NA |
What the finished NCT04194164 record still lists
NCT04194164 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 221-participant average among 38 other Weight Gain trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Weight Gain appearing as the primary indexed condition, and to 1 intervention - of which Fluid intake app is the first listed.
NCT04194164 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04194164 about?
NCT04194164 is a clinical study titled "Development of Fluid Intake App for Management of Fluid Intake During Hemodialysis , Full Scale Trial". Methods are needed to help decrease interdialytic weight gains in hemodialysis patients. One potential method for accomplishing this goal is to develop an app for smartphones that allow patients to track their fluid intake throughout the course of the day. NCT 03759847 was designed to test the safet...
What is the current status of trial NCT04194164?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2019-12-02. Estimated completion is 2021-11-01.
What conditions does trial NCT04194164 study?
This clinical trial studies the following conditions: Weight Gain.
What interventions are being tested in trial NCT04194164?
The interventions under investigation include: Fluid intake app (OTHER).
Who is sponsoring clinical trial NCT04194164?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04194164 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Gain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04194164's enrollment target sits among peer trials
33 27th of 38 higher than 12 of 38 other Weight Gain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Gain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
RECRUITING · NA
-
Testing Responses of Young Adults to Intervention Messages for Promoting Physical Activity Trial
RECRUITING · NA
-
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
RECRUITING · NA
-
Sleep and Metabolism
RECRUITING · NA
-
Exercise, Brain Activity, and Weight Maintenance
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI